Maternal diabetes causes embryonic cranial neural tube defects is associated with elevated H3K18cr and reduced AKT/PIKFYVE
4 affiliations
- 1Department of Biochemistry and Molecular Biology, Shanxi Key Laboratory of Birth Defect and Cell Regeneration, Shanxi Medical University, Taiyuan, 030001 China
- 2Key Laboratory of Coal Environmental Pathogenicity and Prevention, Shanxi Medical University, Ministry of Education, Taiyuan, 030001 China
- 3Shanxi Medical University Third Hospital (Shanxi Bethune Hospital, Shanxi Medical Science Academy Tongji Shanxi Hospital) Anesthesiology Department, Taiyuan, 030001 China
- 4Department of Histology and Embryology, Shanxi Key Laboratory of Birth Defect and Cell Regeneration, Shanxi Medical University, Taiyuan, 030001 China
Abstract
Neural tube defects (NTDs) are severe congenital malformations resulting from incomplete neural tube closure during embryogenesis, with maternal diabetes mellitus being a well-established risk factor. However, the underlying epigenetic mechanisms remain poorly understood. In this study, we established a maternal diabetes mouse model by intraperitoneal injection of streptozotocin at embryonic day (E) 5.5 and examined embryos during the critical neural tube closure period (E8.5–E10.5). Embryos from diabetic dams developed both cranial and spinal NTDs, with a marked predominance of cranial defects; we therefore focused our analyses on cranial neural tissues from affected embryos. In the cranial neural tissue of NTD-affected embryos, we observed significant accumulation of crotonyl-coenzyme A (Cro-CoA), accompanied by elevated levels of lysine crotonylation (Kcr) and histone H3 lysine 18 crotonylation (H3K18cr). Notably, maternal hyperglycemia-induced downregulation of HDAC1 and HDAC2, together with crotonyl-CoA accumulation, promoted a global increase in H3K18cr in cranial neural tissues. However, despite this global elevation, H3K18cr enrichment was paradoxically reduced at the promoters of AKT and PIKFYVE in cranial NTD embryos, correlating with their transcriptional silencing and contributing to cranial NTD pathogenesis. In HT-22 hippocampal neurons, exogenous glucose and crotonate recapitulated the metabolic and epigenetic alterations, leading to Cro-CoA accumulation and a global increase in H3K18cr. However, at the promoters of AKT and PIKFYVE, H3K18cr levels were decreased and consequently suppressed cell proliferation. Our findings demonstrate that maternal diabetes induces NTDs, at least in part, through aberrant elevation of H3K18cr, which suppresses the expression of AKT and PIKFYVE and impairs neural cell proliferation. Our findings reveal a potential regulatory mechanism by which abnormal H3K18cr elevation contributes to the occurrence of cranial NTDs induced by maternal diabetes.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s13072-026-00697-8.
Related
- Elevated Maternal Glycated Albumin is Associated with Large for Gestational Age Infants: Results from a Prospective Longitudinal Study
- Elevated pulse perfusion index values and interleukin-6 levels as associated factors for epidural-related maternal fever: a nested case‒control study
- Triglyceride-rich lipoprotein cholesterol is elevated in liver transplant recipients and associated with post-transplant diabetes
- Elevated autoantibodies against dipeptidyl peptidase-4 are associated with poor prognosis in patients with type 2 diabetes
- Maternal Exercise Rescues Embryonic Osteogenesis Impaired due to POLG Mutation Through a Potential Apelin‐ATF4 Axis
BibTeX
@article{liu2026maternal,
title = {{Maternal diabetes causes embryonic cranial neural tube defects is associated with elevated H3K18cr and reduced AKT/PIKFYVE}},
author = {Zengli Liu and Jiaqi Li and Jingyu Shi and Zhihua Cao and Qi Xie and Yongli Zhao and Xiaolong Gu and Mingquan Liu and Yixiao Yang and Aili Fang and Yanping Yang and Jianting Li and Zhizhen Liu},
journal = {Epigenetics \& Chromatin},
year = {2026},
month = aug,
doi = {10.1186/s13072-026-00697-8},
url = {https://doi.org/10.1186/s13072-026-00697-8},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Maternal diabetes causes embryonic cranial neural tube defects is associated with elevated H3K18cr and reduced AKT/PIKFYVE
AU - Zengli Liu
AU - Jiaqi Li
AU - Jingyu Shi
AU - Zhihua Cao
AU - Qi Xie
AU - Yongli Zhao
AU - Xiaolong Gu
AU - Mingquan Liu
AU - Yixiao Yang
AU - Aili Fang
AU - Yanping Yang
AU - Jianting Li
AU - Zhizhen Liu
PY - 2026
DA - 2026/08/16
JO - Epigenetics & Chromatin
DO - 10.1186/s13072-026-00697-8
UR - https://doi.org/10.1186/s13072-026-00697-8
AB - Neural tube defects (NTDs) are severe congenital malformations resulting from incomplete neural tube closure during embryogenesis, with maternal diabetes mellitus being a well-established risk factor. However, the underlying epigenetic mechanisms remain poorly understood. In this study, we established a maternal diabetes mouse model by intraperitoneal injection of streptozotocin at embryonic day (E) 5.5 and examined embryos during the critical neural tube closure period (E8.5–E10.5). Embryos from diabetic dams developed both cranial and spinal NTDs, with a marked predominance of cranial defects; we therefore focused our analyses on cranial neural tissues from affected embryos. In the cranial neural tissue of NTD-affected embryos, we observed significant accumulation of crotonyl-coenzyme A (Cro-CoA), accompanied by elevated levels of lysine crotonylation (Kcr) and histone H3 lysine 18 crotonylation (H3K18cr). Notably, maternal hyperglycemia-induced downregulation of HDAC1 and HDAC2, together with crotonyl-CoA accumulation, promoted a global increase in H3K18cr in cranial neural tissues. However, despite this global elevation, H3K18cr enrichment was paradoxically reduced at the promoters of AKT and PIKFYVE in cranial NTD embryos, correlating with their transcriptional silencing and contributing to cranial NTD pathogenesis. In HT-22 hippocampal neurons, exogenous glucose and crotonate recapitulated the metabolic and epigenetic alterations, leading to Cro-CoA accumulation and a global increase in H3K18cr. However, at the promoters of AKT and PIKFYVE, H3K18cr levels were decreased and consequently suppressed cell proliferation. Our findings demonstrate that maternal diabetes induces NTDs, at least in part, through aberrant elevation of H3K18cr, which suppresses the expression of AKT and PIKFYVE and impairs neural cell proliferation. Our findings reveal a potential regulatory mechanism by which abnormal H3K18cr elevation contributes to the occurrence of cranial NTDs induced by maternal diabetes. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s13072-026-00697-8.
SN - 1756-8935
ER -